Journal of magnetic resonance imaging : JMRI
-
J Magn Reson Imaging · Nov 2021
Randomized Controlled TrialAssociation Between T2 * Relaxation Times Derived From Ultrashort Echo Time MRI and Symptoms During Exercise Therapy for Patellar Tendinopathy: A Large Prospective Study.
Exercise therapy is considered preferential treatment for patellar tendinopathy (PT). However, there is conflicting evidence for structural patellar tendon adaptation in response to exercise therapy and its association with symptoms is weak. ⋯ 1 TECHNICAL EFFICACY: Stage 4.
-
J Magn Reson Imaging · Oct 2021
Randomized Controlled TrialMultiparametric Magnetic Resonance Imaging-Based Peritumoral Radiomics for Preoperative Prediction of the Presence of Extracapsular Extension With Prostate Cancer.
Preoperative prediction of extracapsular extension (ECE) of prostate cancer (PCa) is important to guide clinical decision-making and improve patient prognosis. ⋯ The peritumoral radiomics can better predict the presence of ECE preoperatively compared with the intratumoral radiomics and may have better generalization than clinical characteristics. EVIDENCE LEVEL: 4 TECHNICAL EFFICACY: 2.
-
J Magn Reson Imaging · Oct 2021
Randomized Controlled TrialRadiomics Nomograms Based on Non-enhanced MRI and Clinical Risk Factors for the Differentiation of Chondrosarcoma from Enchondroma.
Differentiating chondrosarcoma from enchondroma using conventional MRI remains challenging. An effective method for accurate preoperative diagnosis could affect the management and prognosis of patients. ⋯ 4 TECHNICAL EFFICACY: Stage 2.
-
J Magn Reson Imaging · Sep 2020
Randomized Controlled TrialMultiparametric MRI-Based Radiomics Nomogram for Predicting Lymph Node Metastasis in Early-Stage Cervical Cancer.
Lymph node metastasis (LNM) is a critical risk factor affecting treatment strategy and prognosis in patients with early-stage cervical cancer. ⋯ 3 TECHNICAL EFFICACY STAGE: 2 J. Magn. Reson. Imaging 2020;52:885-896.
-
J Magn Reson Imaging · Dec 2019
Randomized Controlled Trial Multicenter Study Comparative StudyAdditive value of diffusion-weighted MRI in the I-SPY 2 TRIAL.
The change in apparent diffusion coefficient (ADC) measured from diffusion-weighted imaging (DWI) has been shown to be predictive of pathologic complete response (pCR) for patients with locally invasive breast cancer undergoing neoadjuvant chemotherapy. ⋯ 2 Technical Efficacy Stage: 4 J. Magn. Reson. Imaging 2019;50:1742-1753.